We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Magnetic Resonance Imaging of the Coronary Vessel Wall

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00456950
Recruitment Status : Completed
First Posted : April 5, 2007
Last Update Posted : September 24, 2009
Information provided by:
Maastricht University Medical Center

Brief Summary:

Despite advances in prevention and treatment, clinical manifestations of atherosclerosis (e.g. myocardial infarction, stroke) remain the largest cause of mortality in the Western world. The occurrence of acute ischemic syndromes, including unstable angina and myocardial infarction, is highly associated with atherosclerotic plaque morphology.

Magnetic resonance (MR) imaging is able to noninvasively depict the lumen of coronary arteries without the need for ionizing radiation. In addition, MR imaging is able to generate soft-tissue contrast unlike any other imaging modality. It has been shown in the aorta and carotid artery that MR imaging is able to identify different atherosclerotic plaque components in vivo. Similar MR imaging techniques are becoming available to visualize the coronary arterial wall and preliminary studies have shown the feasibility of MR coronary vessel wall imaging in humans.

The overall aim of the current study is to identify in vivo MR coronary vessel wall and plaque features that are associated with acute coronary syndromes. This study is divided into 2 substudies:

  1. Detection of atherosclerosis in the coronary vessel wall with contrast-enhanced MR imaging in patients with coronary artery disease and age-matched healthy volunteers.
  2. Characterization of coronary vessel wall plaque morphology in patients with stable and unstable angina: validation of MRI with the current standard of reference intravascular ultrasound (IVUS).

Condition or disease
Coronary Artery Disease

Study Type : Observational
Actual Enrollment : 75 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Detection of Vulnerable Plaque With Coronary Vessel Wall Magnetic Resonance Imaging
Study Start Date : October 2005
Primary Completion Date : June 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
  • Patients with (un)stable angina or non-st-elevated myocardial infarction: sample from dept. of cardiology
  • healthy volunteers: community sample

Inclusion Criteria:

  • patients with (un)stable angina or non-ST-elevated myocardial infarction
  • patients are scheduled for, or recently had X-ray coronary angiography
  • healthy volunteers, no clinical history of coronary artery disease(control group for substudy 1)
  • patients with non-ischemic heart disease, scheduled for X-ray coronary angiography (control group for substudy 2)
  • informed consent

Exclusion Criteria:

  • severe arrhythmia
  • hemodynamic unstable patients
  • contra-indications for MRI

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00456950

Maastricht University Hospital
Maastricht, Netherlands, 6229 HX
Sponsors and Collaborators
Maastricht University Medical Center
Principal Investigator: Tim Leiner, MD, PhD Maastricht University Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: T. Leiner, M.D., PhD, Dept. of Radiology, Maastricht University Hospital
ClinicalTrials.gov Identifier: NCT00456950     History of Changes
Other Study ID Numbers: MEC 04-272
First Posted: April 5, 2007    Key Record Dates
Last Update Posted: September 24, 2009
Last Verified: September 2009

Keywords provided by Maastricht University Medical Center:
coronary atherosclerosis
magnetic resonance imaging
vulnerable plaque

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases